Defining two subpopulations of marginal zone B cells
Cellular & Molecular Immunology, Published online: 27 March 2024; doi:10.1038/s41423-024-01141-1Defining two subpopulations of marginal zone B cells
Cellular & Molecular Immunology, Published online: 27 March 2024; doi:10.1038/s41423-024-01141-1Defining two subpopulations of marginal zone B cells
Cellular & Molecular Immunology, Published online: 26 March 2024; doi:10.1038/s41423-024-01152-yThe chemerin-CMKLR1 axis in keratinocytes impairs innate host defense against cutaneous Staphylococcus aureus infection
Cellular & Molecular Immunology, Published online: 26 March 2024; doi:10.1038/s41423-024-01138-wNovel insights into regulation of butyrophilin molecules: critical components of cancer immunosurveillance by γδ T cells
Cellular & Molecular Immunology, Published online: 21 March 2024; doi:10.1038/s41423-024-01154-wAerobic glycolysis enables the effector differentiation potential of stem-like CD4+ T cells to combat cancer
Cellular & Molecular Immunology, Published online: 19 March 2024; doi:10.1038/s41423-024-01151-zInsm1: orchestrating cellular mimicry in the thymus medulla
Cellular & Molecular Immunology, Published online: 12 March 2024; doi:10.1038/s41423-024-01146-wNeutrophil ALDH2 is a new therapeutic target for the effective treatment of sepsis-induced ARDS
Cellular & Molecular Immunology, Published online: 08 March 2024; doi:10.1038/s41423-024-01140-2Mucosal T-cell responses to chronic viral infections: Implications for vaccine design
Cellular & Molecular Immunology, Published online: 08 March 2024; doi:10.1038/s41423-024-01147-9Neutrophils in the tumor microenvironment – when a company becomes a crowd
Cellular & Molecular Immunology, Published online: 06 March 2024; doi:10.1038/s41423-024-01142-0Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2
Cellular & Molecular Immunology, Published online: 05 March 2024; doi:10.1038/s41423-024-01145-xDevelopment of NK cell-based cancer immunotherapies through receptor engineering